Clinical Trial Update: Ischemic Optic Neuropathy Decompression Trial (IONDT) [Phase 3]

View source ↗

Summary

The Phase 3 Ischemic Optic Neuropathy Decompression Trial (IONDT) has completed its study activities.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Optic Neuropathy

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Ischemic Optic Neuropathy | Phase 3 | Status: COMPLETED